SCHEMBL4446281

SCHEMBL4446281

C[Si](C)(C)O[SiH2]O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15693307 0.77
SCHEMBL170189 0.74
SCHEMBL17546227 0.74
SCHEMBL15899089 0.69
SCHEMBL16785532 0.67
SCHEMBL457207 0.67
SCHEMBL3860101 0.67
SCHEMBL6032174 0.65
SCHEMBL18365311 0.64
SCHEMBL4910123 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260132295-A1 COMPOUND, COMPOSITION, SURFACE TREATMENT AGENT, METHOD FOR MANUFACTURING ARTICLE, AND ARTICLE AGC Inc. (JP) 2026-05-14 US disclosed
CN-118299471-A Preparation method of back P-I-N structure and preparation method of efficient crystalline silicon battery 常州时创能源股份有限公司 2024-07-05 CN disclosed
CN-117720694-A Multi-monomer silicon material mixed copolymerization silicon hydrogel material, preparation method and application thereof, and preparation method of cornea contact lens 海昌隐形眼镜有限公司 2024-03-19 CN disclosed
EP-2490679-B1 METHODS OF MAKING AND USING COMPOSITIONS COMPRISING FLAVONOIDS VIZURI HEALTH SCIENCES CONSUMER HEALTHCARE INC T/A VHS CONSUMER HEALTHCARE (US) 2022-09-21 EP disclosed
EP-3345594-B1 SOLUBILIZED FLAVONOID COMPOSITION TECH INVESTMENTS LC (US) 2021-11-17 EP disclosed
EP-3356356-B1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED (US) 2021-05-26 EP disclosed
US-20210069496-A1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION OCULEVE INC (US) 2021-03-11 US disclosed
US-10799696-B2 Polymer formulations for nasolacrimal stimulation OCULEVE, INC. (US) 2020-10-13 US disclosed
EP-3689338-A1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION Oculeve, Inc. (US) 2020-08-05 EP disclosed
CN-111298285-A Polymer formulations for nasolacrimal stimulation 奥库利维公司 2020-06-19 CN disclosed
WO-2013050401-A2 POLYMERS BASED ON BENZODIONES BASF SE (DE) 2013-04-11 WO disclosed
EP-2125833-A1 METHOD FOR THE PRODUCTION OF POLYMERISABLE SILICONES Wacker Chemie AG (DE) 2009-12-02 EP disclosed
EP-2125834-A1 METHOD FOR THE PRODUCTION OF POLYMERISABLE SILICONES Wacker Chemie AG (DE) 2009-12-02 EP disclosed
WO-2008090013-A1 METHOD FOR THE PRODUCTION OF POLYMERISABLE SILICONES WACKER CHEMIE AG (DE) 2008-07-31 WO disclosed
WO-2008090012-A1 METHOD FOR THE PRODUCTION OF POLYMERISABLE SILICONES WACKER CHEMIE AG (DE) 2008-07-31 WO disclosed
US-6995225-B2 Proton conduction material and method of manufacturing the same TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2006-02-07 US disclosed
US-20040106043-A1 Proton conduction material and method of manufacturing the same TOYOTA JIDOSHA KABUSHIKI KAISHA 2004-06-03 US disclosed
EP-0587662-A1 ORGANO(POLY)SILOXANE COMPOSITIONS WHICH CAN BE CROSS-LINKED TO FORM ELASTOMERS WITH SEPARATION OF ALCOHOLS. WACKER CHEMIE GMBH (DE) 1994-03-23 EP disclosed
WO-1992021724-A2 ORGANO(POLY)SILOXANE COMPOSITIONS WHICH CAN BE CROSS-LINKED TO FORM ELASTOMERS WITH SEPARATION OF ALCOHOLS WACKER-CHEMIE GMBH (DE) 1992-12-10 WO disclosed
US-4852969-A PROTECTIVE COATING AND CLADDING OF HIGH ADHESION MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-08-01 US disclosed